Klaus Mendla

Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA.

Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.

Part of Tripos, Inc., Receptor Research Ltd. provides drug discovery informatics products and services. The company is based in Bude, UK. Receptor Research was acquired by Tripos, Inc. on November 18, 1997.

The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists.

Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany.

Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT.

Azellon Ltd. develops stem cell therapy for the repair of avascular meniscal tears. The firm's meniscal repair technology combines bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. The company was founded by Anthony Hollander and Troels Jordansen in 2007 and is headquartered in London, the United Kingdom.

Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd

Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom.

Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom.

Consorzio per il Centro di Biomedicina Molecolare SCRL develops local health programs. It manages projects and organizes activities in the biomedicine, biotechnology, and bioinformatics sectors. The company is headquartered in Trieste, Italy.

Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford.

The Institute of Molecular & Cell Biology engages in biomedical research. The non-profit company is based in Singapore, Singapore.

Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom.

Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA.

Health Catalyst Capital Management LLC (Health Catalyst Capital) is a private equity and venture capital firm founded in 2015 by Charles Boorady. The firm is headquartered in New York.

Pulse Infoframe, Inc. operates as a cloud-based health care analytics company. Its products include dynamic registries, patient reported outcomes, visualizations and analytics, patient engagement portal. The firm's services include collaborative clinical research, workflow optimization, consulting, cloud enabled global sourcing, interoperability and deployment services. The company was founded by Femida Gwadry-Sridhar in 2011 and is headquartered in London, Canada.

Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom.

Xperiome Ltd. operates online community platform. Its services include online health communities, patient education, career education, and patient recruitment. The company was founded by Julie Walters and Peter Coe in 2007 and is headquartered in London, the United Kingdom.

Genialis, Inc. develops software for biologists in solving complex analyses. The software helps in automation of data and analyzing task for exploring and sharing the results. The company is headquartered in Houston, TX.

EspeRare Foundation offers treatments for rare diseases. The non-profit company is based in Geneva, Switzerland.

Duality Technologies, Inc. engages in privacy enhancing technologies. Its products include secure data analysis; IP protection for analytics models; and privacy-preserving data linkage. The company was founded by Alon Kaufman, Shafi Glodwasser, Rina Shainski, Kurt Rohloff, and Vinod Vaikuntanathan in 2016 and is headquartered in Maplewood, NJ.

Leapcure, Inc. is an American patient-centric clinical trial solutions company founded in 2015 by Zachary Gobst, Tyler Dornenburg, Kyle W Eaton, and Luis De Avila. The company is based in the United States and is committed to expediting patient recruitment and helping to bring vital treatments to the market faster. Leapcure connects patients and research to elevate the patient's voice in the process, delivering patient participation to accelerate research innovations. The company's approach is rooted in cutting-edge technology and deep industry knowledge, combining advanced data analytics, a hands-on patient care team, and patient advocacy partnerships to support patients, research sites, and biotech companies in their clinical research. Discover patient-centric clinical trial solutions at leapcure.com.

Huma.AI, Inc develops automation platform for the pharmaceutical and healthcare industry. The company was founded by Lana Feng, Gregory P. Kostello, and Chang Sung Yu and is headquartered in Palo Alto, CA.

Entropica Labs Pte Ltd. develops quantum computing software and algorithms for computational genomics and the life sciences. The firm offers Entropica QAOA and Quantum Machine Learning Lab. The company was founded by Tommaso Demarie, Ewan Munro and Joaquin Keller in May 2018 and is headquartered in Singapore.

Reach52 Asia Pte Ltd. engages in the provision of accessible and affordable healthcare services to communities where healthcare access is limited. It offers services to communities, healthcare providers, governments, multi-laterals, and institutions. The company was founded by Ed Booty in 2017 and is headquartered in Singapore.

Argobio SAS is a start-up studio founded in 2021 and based in Paris, FR. The company was initiated by Kurma Partners, a leading healthcare venture capital firm based in France, and Bpifrance, the French national investment bank. The French company aims to nurture and launch at least five breakthrough biotech companies over the next five years by sourcing innovative early-stage projects from renowned European academic research institutions. The focus is on selected therapeutic areas, including rare diseases, neurological disorders, oncology, and immunology. Argobio will identify, select, and incubate these projects up to company creation and beyond, providing broad expertise in the discovery and development of novel drugs with a team of highly experienced biotech entrepreneurs. The internal team is led by Yves Ribeill, Neill Mackenzie, Poul Sørensen, and Rémi Soula. Thierry Laugel, Managing Partner at Partners, is the President of Argobio. Kurma and Bpifrance were joined by complementary strategic investors, Angelini Pharma, a private international pharmaceutical company, Evotec, a drug discovery alliance and development partnership company, and the Institut Pasteur, an internationally renowned center for biomedical research.

Pluto Health, Inc. is a company that focuses on providing the best insights on your health. The company is based in Durham, NC. The company believes that individuals have power over their own health data and are committed to empowering their customers. The company offers deep insights on patient health, including identifying gaps in care and auxiliary social determinants of health. The company's services include geolocation health services. It was founded by Guru Kora and Satasuk Joy Bhosai, with Satasuk Joy Bhosai serving as the CEO.

Pretzel Therapeutics, Inc. is an American biotechnology company that develops therapies by utilizing mitochondrial biology. Pretzel Therapeutics is based in an undisclosed location and has research facilities in another undisclosed location. The company aims to develop treatments that address the genetic causes of mitochondrial dysfunction. The company was founded by academic experts in mitochondrial biology and is supported by a world-class investor syndicate. Jay Parrish has been the CEO of the company since 2021.